Clinical Trial Update: MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing MESA versus ESA for early-stage Extranodal NK/T-cell Lymphoma, Nasal Type; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma Nasal Type

Drugs mentioned

• ESA
• MESA

Snippet

Sponsor: Ruijin Hospital | Conditions: Extranodal NK/T-cell Lymphoma, Nasal Type | Phase 3 | Status: UNKNOWN